Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
1986-2-24
pubmed:abstractText
The distribution of the conventional lymphoid cell markers on T lymphocytes and the principal panels of monoclonal antibodies used to recognize distinctive T-lymphocyte-associated differentiation antigens are discussed. These reagents have been used to probe the early and late stages of T-cell differentiation, and a hypothetical schema of T-cell differentiation has been constructed. Application of these reagents to the investigation of neoplastic T cells has resulted in the determination of the subset of origin and the stage of differentiation of the neoplastic cells in T-cell-derived lymphoproliferative malignancies. Recent advances in molecular biology have made possible the Southern blot hybridization analysis of DNA extracted from neoplastic T cells for patterns of T-cell-receptor gene rearrangements. Examination of these patterns in benign and malignant T and non-T cell has provided the basis for the use of T-cell-receptor gene rearrangements as specific genetic markers of T-cell lineage, clonality, and differentiation. These and other advances have resulted in the delineation of a new category of T-cell neoplasia, the adult T-cell leukemia/lymphoma syndrome. They have also demonstrated that the majority of clinically indolent neoplasms composed of large granular lymphocytes in so-called T gamma-lymphoproliferative disease are monoclonal proliferations. Further phenotypic, functional, and genotypic analyses of the T-cell malignancies should provide better understanding of T-lymphocyte differentiation and heterogeneity. Such studies should also lead to better clinicopathologic correlations and greater understanding of the basis for the clinical diversity of the T-cell-derived lymphoproliferative malignancies.
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jan
pubmed:issn
0046-8177
pubmed:author
pubmed:issnType
Print
pubmed:volume
17
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
14-33
pubmed:dateRevised
2007-11-15
pubmed:meshHeading
pubmed-meshheading:3002948-Adult, pubmed-meshheading:3002948-Aged, pubmed-meshheading:3002948-Antibodies, Monoclonal, pubmed-meshheading:3002948-Antigens, pubmed-meshheading:3002948-Antigens, Differentiation, T-Lymphocyte, pubmed-meshheading:3002948-Antigens, Surface, pubmed-meshheading:3002948-Atlantic Islands, pubmed-meshheading:3002948-B-Lymphocytes, pubmed-meshheading:3002948-Cell Differentiation, pubmed-meshheading:3002948-Cell Nucleus, pubmed-meshheading:3002948-Child, pubmed-meshheading:3002948-Child, Preschool, pubmed-meshheading:3002948-Clone Cells, pubmed-meshheading:3002948-Cytoplasm, pubmed-meshheading:3002948-DNA, pubmed-meshheading:3002948-DNA Restriction Enzymes, pubmed-meshheading:3002948-Deltaretrovirus, pubmed-meshheading:3002948-Female, pubmed-meshheading:3002948-Genotype, pubmed-meshheading:3002948-HLA-DR Antigens, pubmed-meshheading:3002948-Histocompatibility Antigens Class II, pubmed-meshheading:3002948-Histocytochemistry, pubmed-meshheading:3002948-Humans, pubmed-meshheading:3002948-Immunoglobulins, pubmed-meshheading:3002948-Japan, pubmed-meshheading:3002948-Leukemia, Lymphoid, pubmed-meshheading:3002948-Leukocyte Count, pubmed-meshheading:3002948-Lymphoproliferative Disorders, pubmed-meshheading:3002948-Male, pubmed-meshheading:3002948-Middle Aged, pubmed-meshheading:3002948-Nucleic Acid Hybridization, pubmed-meshheading:3002948-Phenotype, pubmed-meshheading:3002948-Prognosis, pubmed-meshheading:3002948-Receptors, Immunologic, pubmed-meshheading:3002948-Retroviridae Infections, pubmed-meshheading:3002948-Rosette Formation, pubmed-meshheading:3002948-Sex Factors, pubmed-meshheading:3002948-T-Lymphocytes, pubmed-meshheading:3002948-T-Lymphocytes, Helper-Inducer, pubmed-meshheading:3002948-T-Lymphocytes, Regulatory, pubmed-meshheading:3002948-United States
pubmed:year
1986
pubmed:articleTitle
The human T-cell leukemias: clinical, cytomorphologic, immunophenotypic, and genotypic characteristics.
pubmed:publicationType
Journal Article, Comparative Study, Research Support, U.S. Gov't, P.H.S., Review, Research Support, Non-U.S. Gov't